Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Parkinson's Disease - Market Insights, Epidemiology and Market Forecast - 2025

ReportBuyer
Posted on: 10 Nov 17
Parkinson's Disease - Market Insights, Epidemiology and Market Forecast - 2025 DelveInsight's "Parkinson's Disease - Market Insights, Epidemiology and Market Forecast - 2025"report provides an overview of Parkinson's disease (PD), epidemiology and market trend of the Parkinson's disease (PD) for the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

PR Newswire

LONDON, Nov.9, 2017

LONDON, Nov.9, 2017 /PRNewswire/ -- Download the full report: https://www.reportbuyer.com/product/4985959

The Report covers the therapeutics market revenue, treatment practice/algorithm and forecasted market size of Parkinson's disease (PD) from 2017 to 2025 segmented by seven major markets. In addition, the report also includes the forecasted epidemiology of Parkinson's disease (PD) till 2025. It also covers market drivers, market barriers and unmet medical need.

This report provides the diagnosed cases of Parkinson's disease (PD). Changes in diagnostic practice over time and increase in aging population will slowly increase the diagnosed cases of PD. According to DelveInsight, the prevalent population of Parkinson's disease (PD) is expected to reach up to XXX cases by the end of 2025 at a CAGR of 4.69% from 2015-2025. High prevalent cases were observed in United States as compared to EU5 and Japan.

The market size is driven by several approved drugs that are being used for the treatment of Parkinson's disease such as Neupro (UCB Group of Companies), Xadago (Newron Pharmaceuticals S.p.A.) and Exelon (Novartis).

United States contributes the major share of Parkinson's disease (PD) market as compared to EU5 countries and Japan. The therapeutic market of PD in 7MM is expected to reach USD 4.91 Billion in 2025 at the CAGR of XX% from 2015-2025.

Key Coverage and Benefits:

  • The report will help in developing business strategies by understanding the trends shaping and driving the global Parkinson's disease (PD) market.
  • Organize sales and marketing efforts by identifying the best opportunities for Parkinson's disease in US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.
  • To understand the future market competition in the Parkinson's disease market and Insightful review of the key market drivers and barriers.
  • To understand the regulatory scenario in major markets.
  • The report provides historical as well as forecasted epidemiology of Parkinson's disease in the 7MM covering United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan from 2015-2025.
  • The Report also covers the detailed historical and forecasted Parkinson's disease market covering United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan from 2015-2025.

Download the full report: https://www.reportbuyer.com/product/4985959

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
https://www.reportbuyer.com  

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

View original content:http://www.prnewswire.com/news-releases/parkinsons-disease---market-insights-epidemiology-and-market-forecast--2025-300553658.html

SOURCE ReportBuyer

PR Newswire
www.prnewswire.com

Last updated on: 10/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.